A guide to in silico vaccine discovery for eukaryotic pathogens

Briefings in Bioinformatics

Volumn 14, Issue 6, 2013, Pages 753-774

  Goodswen, Stephen J ^a   Kennedy, Paul J ^a   Ellis, John T ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Apicomplexans; Eukaryotic pathogens; Immunoinformatics; In silico vaccine discovery; Reverse vaccinology

Indexed keywords

VACCINE;

APICOMPLEXA; ARTICLE; COMPUTER SIMULATION; EUKARYOTIC CELL; EUKARYOTIC PATHOGENS; IMMUNOINFORMATICS; IMMUNOLOGY; IN SILICO VACCINE DISCOVERY; REVERSE VACCINOLOGY;

APICOMPLEXANS; EUKARYOTIC PATHOGENS; IMMUNOINFORMATICS; IN SILICO VACCINE DISCOVERY; REVERSE VACCINOLOGY;

COMPUTER SIMULATION; EUKARYOTIC CELLS; VACCINES;

EID: 84887669298     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbs066     Document Type: Article

References (131)

1. Rappuoli R. Reverse vaccinology. Curr Opin Microbiol 2000;3:445-50.
2. Ariel N, Zvi A, Grosfeld H, et al. Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun 2002;70:6817-27.
3. Montigiani S, Falugi F, Scarselli M, et al. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun 2002;70:368-79.
4. Ross BC, Czajkowski L, Hocking D, et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine 2001;19:4135-42.
5. Serruto D, Rappuoli R, Pizza M. Meningococcus B: From Genome to Vaccine. Genomics, Proteomics and Vaccines. Chichester: John Wiley & Sons, Ltd, 2005;183-204.
6. Wizemann TM, Heinrichs JH, Adamou JE, et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 2001;69:1593-8.
7. Mora M, Donati C, Medini D, et al. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. Curr OpinMicrobiol 2006;9:532-6.
8. Che F-Y, Madrid-Aliste C, Burd B, et al. Comprehensive proteomic analysis of membrane proteins in Toxoplasma gondii. Mol Cell Proteomics 2011;10: M110.000745.
9. Kim K, Weiss LM. Toxoplasma gondii: the model apicomplexan. IntJ Parasitol 2004;34:423-32.
10. Roos DS. Themes and variations in apicomplexan parasite biology. Science 2005;309:72-3.
11. Flower DR, Macdonald IK, Ramakrishnan K, et al. Computer aided selection of candidate vaccine antigens. ImmunomeRes 2010;6(Suppl 2):S1.
12. Horton P, Park K-J, Obayashi T, et al. WoLF PSORT: protein localization predictor. Nucleic Acids Res 2007;35: W585-7.
13. Claverie J-M, Poirot O, Lopez F. The difficulty of identifying genes in anonymous vertebrate sequences. ComputChem 1997;21:203-14.
14. Fickett JW. The gene identification problem: an overview for developers. Comput Chem 1996;20:103-18.
15. Fickett JW. Finding genes by computer: the state of the art. TrendsGenet 1996;12:316-20.
16. Guigó R. Computational gene identification: an open problem. Comput Chem 1997;21:215-22.
17. Guigó R, Agarwal P, Abril JF, et al. An assessment of gene prediction accuracy in large DNA sequences. Genome Res 2000;10:1631-42.
18. Korf I. Gene finding in novel genomes. BMCBioinformatics 2004;5:59.
19. Mathé C, Sagot MF, Schiex T, et al. Current methods of gene prediction, their strengths and weaknesses. Nucleic Acids Res 2002;30:4103-17.
20. Borodovsky M, Rudd KE, Koonin EV. Intrinsic and extrinsic approaches for detecting genes in a bacterial genome. Nucleic Acids Res 1994;22:4756-67.
21. van Baren MJ, Koebbe BC, Brent MR. Using N-SCAN or TWINSCAN to predict gene structures in genomic DNA sequences. Curr Protoc Bioinformatics 2007. Chapter 4:Unit 4.8.
22. Bork P. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 2000;10:398-400.
23. Xu Y, Mural RJ, Einstein JR, et al. GRAIL: a multi-agent neural network system for gene identification. Proc IEEE 1996;84:1544-52.
24. Parra G, Blanco E, Guigo R. GeneID in drosophila. Genome Res 2000;10:511-5.
25. Snyder EE, Stormo GD. Identification of coding regions in genomic DNA-sequences-an application of dynamicprogramming and neural networks. Nucleic Acids Res 1993; 21:607-13.
26. Solovyev VV, Salamov AA, Lawrence CB. Identification of human gene structure using linear discriminant functions and dynamic programming. Proc Int Conf Intell SystMol Biol 1995;3:367-75.
27. Kulp D, Haussler D, Reese MG, et al. A generalized hidden Markov model for the recognition of human genes in DNA. Proc Int Conf Intell SystMolBiol 1996;4:134-42.
28. Gelfand MS, Mironov AA, Pevzner PA. Gene recognition via spliced sequence alignment. ProcNatlAcad SciUSA 1996; 93:9061-6.
29. Salamov AA, Solovyev VV. Ab initio gene finding in drosophila genomic DNA. GenomeRes 2000;10:516-22.
30. Burge C, Karlin S. Prediction of complete gene structures in human genomic DNA. JMol Biol 1997;268:78-94.
31. Krogh A. Two methods for improving performance of an HMM and their application for gene finding. Proc Int Conf Intell SystMol Biol 1997;5:179-86.
32. Birney E, Durbin R. Dynamite: a flexible code generating language for dynamic programming methods used in sequence comparison. Proc IntConf Intell Syst Mol Biol 1997;5: 56-64.
33. Lukashin AV, Borodovsky M. GeneMark.hmm: new solutions for gene finding. Nucleic Acids Res 1998;26:1107-15.
34. Yeh RF, Lim LP, Burge CB. Computational inference of homologous gene structures in the human genome. Genome Res 2001;11:803-816.
35. Howe KL, Chothia T, Durbin R. GAZE: a generic framework for the integration of gene-prediction data by dynamic programming. Genome Res 2002;12:1418-27.
36. Hubbard T, Barker D, Birney E, et al. The Ensembl genome database project. Nucleic Acids Res 2002;30:38-41.
37. Majoros WH, Pertea M, Salzberg SL. TigrScan and GlimmerHMM: two open source ab initio eukaryotic gene-finders. Bioinformatics 2004;20:2878-9.
38. Stanke M, Steinkamp R, Waack S, et al. AUGUSTUS: a web server for gene finding in eukaryotes. Nucleic Acids Res 2004;32:W309-12.
39. Stanke M, Tzvetkova A, Morgenstern B. AUGUSTUS at EGASP: using EST, protein and genomic alignments for improved gene prediction in the human genome. Genome Biol 2006;7:S11.
40. Gross S, Brent M. Using multiple alignments to improve gene prediction. JComputBiol 2006;13:379-93.
41. Wei CC, Brent MR. Using ESTs to improve the accuracy of de novo gene prediction. BMC Bioinformatics 2006; 7:327.
42. DeCaprio D, Vinson JP, Pearson MD, et al. Conrad: gene prediction using conditional random fields. Genome Res 2007;17:1389-98.
43. Gross SS, Do CB, Sirota M, et al. CONTRAST: a discriminative, phylogeny-free approach to multiple informant de novo gene prediction. Genome Biol 2007;8:R269.
44. Schweikert G, Behr J, Zien A, et al. mGene.web: a web service for accurate computational gene finding. Nucleic Acids Res 2009;37:W312-6.
45. Pertea M, Salzberg SL. Using GlimmerM to find genes in eukaryotic genomes. Curr Protoc Bioinform 2002. Chapter 4:Unit 4.4.
46. Sleator RD. An overview of the current status of eukaryote gene prediction strategies. Gene 2010;461:1-4.
47. Brent MR. How does eukaryotic gene prediction work? Nat Biotech 2007;25:883-5.
48. Kent WJ. BLAT-The BLAST-like alignment tool. Genome Res 2002;12:656-64.
49. Wu T, Watanabe C. GMAP: a genomic mapping and alignment program for mRNA and EST sequences. Bioinformatics 2005;21:1859-75.
50. Parra Gs, Agarwal P, Abril JF, et al. Comparative gene prediction in human and mouse. Genome Res 2003;13: 108-17.
51. Alexandersson M, Cawley S, Pachter L. SLAM: crossspecies gene finding and alignment with a generalized pair hidden Markov model. Genome Res 2003;13:496-502.
52. Richards JE, Hawley RS. The central dogma of molecular biology: how cells orchestrate the use of genetic information. In: TheHumanGenome. 3rd edn. San Diego: Academic Press, 2011;83-113.
53. Emanuelsson O. Predicting protein subcellular localisation from amino acid sequence information. BriefBioinform 2002; 3:361-76.
54. Emanuelsson O, Brunak S, von Heijne G, et al. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protocols 2007;2:953-71.
55. Foth BJ, Ralph SA, Tonkin CJ, et al. Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. Science 2003;299:705-8.
56. Nielsen H, Brunak S, von Heijne G. Machine learning approaches for the prediction of signal peptides and other protein sorting signals. Protein Eng 1999;12:3-9.
57. Dyrløv Bendtsen J, Nielsen H, von Heijne G, et al. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004;340:783-95.
58. Nielsen H, Engelbrecht J, Brunak S, et al. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997;10:1-6.
59. Emanuelsson O, Nielsen H, Brunak S, et al. Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. JMol Biol 2000;300:1005-16.
60. Krogh A, Larsson B, von Heijne G, et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001; 305:567-80.
61. Möller S, Croning MDR, Apweiler R. Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics 2001;17:646-53.
62. Blom N, Sicheritz-Pontén T, Gupta R, et al. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 2004;4: 1633-49.
63. Garavelli JS. The RESID database of protein modifications: 2003 developments. Nucleic Acids Res 2003;31:499-501.
64. Malcolm J. McConville AKM. Recent developments in the cell biology and biochemistry of glycosylphosphatidylinositol lipids (Review). Mol Membrane Biol 2000;17:1-16.
65. Pierleoni A, Martelli P, Casadio R. PredGPI: a GPI-anchor predictor. BMC Bioinformatics 2008;9:392.
66. Eisenhaber B, Bork P, Eisenhaber F. Prediction of potential GPI-modification sites in proprotein sequences. J Mol Biol 1999;292:741-58.
67. Fankhauser N, Mäser P. Identification of GPI anchor attachment signals by a Kohonen self-organizing map. Bioinformatics 2004;21:1846-52.
68. Poisson G, Chauve C, Chen X, et al. FragAnchor: a large-scale predictor of glycosylphosphatidylinositol anchors in eukaryote protein sequences by qualitative scoring. Genomics Proteomics Bioinformatics 2007;5:121-30.
69. Korber B, LaBute M, Yusim K. Immunoinformatics comes of age. PLoSComput Biol 2006;2:484-92.
70. Zhao B, Sakharkar K, Lim C, et al. MHC-peptide binding prediction for epitope based vaccine design. Int J Integr Biol 2007;1:127-40.
71. Yang X, Yu X. An introduction to epitope prediction methods and software. RevMedVirol 2009;19:77-96.
72. Lundegaard C, Hoof I, Lund O, et al. State of the art and challenges in sequence based T-cell epitope prediction. ImmunomeRes 2010;6(Suppl 2):S3.
73. Tong JC, Tan TW, Ranganathan S. Methods and protocols for prediction of immunogenic epitopes. Brief Bioinform 2007;8:96-108.
74. Tsurui R, Takahashi T. Prediction of T-cell epitope. J Pharmacol Sci 2007;105:299-316.
75. Knapp B, Omasits U, Frantal S, et al. A critical cross-validation of high throughput structural binding prediction methods for pMHC. JComputAidedMolDes 2009;23:301-7.
76. Lin HH, Zhang GL, Tongchusak S, et al. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMCBioinformatics 2008;9(Suppl 12):S22.
77. Zhang GL, Ansari HR, Bradley P, et al. Machine learning competition in immunology-prediction of HLA class I binding peptides. J ImmunolMethods 2011;374:1-4.
78. Nielsen M, Lundegaard C, Worning P, et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003;12:1007-17.
79. Bui H-H, Sidney J, Peters B, et al. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 2005;57:304-14.
80. Peters B, Sette A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 2005;6:132.
81. Sidney J, Assarsson E, Moore C, et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immun Res 2008;4:2.
82. Moutaftsi M, Peters B, Pasquetto V, et al. A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus. Nat Biotechnol 2006;24:817-9.
83. Hoof I, Peters B, Sidney J, et al. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009;61:1-13.
84. Doytchinova IA, Flower DR. Class I T-cell epitope prediction: improvements using a combination of proteasome cleavage, TAP affinity, and MHC binding. Mol Immunol 2006;43:2037-44.
85. Larsen MV, Lundegaard C, Lamberth K, et al. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 2005;35:2295-03.
86. Wang P, Sidney J, Dow C, et al. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 2008;4: e1000048.
87. Nielsen M, Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 2009;10:269.
88. Nielsen M, Lundegaard C, Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 2007;8:238.
89. Sturniolo T, Bono E, Ding JY, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999;17:555-61.
90. Bian HJ, Hammer J. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE. Methods 2004;34:468-75.
91. Nielsen M, Justesen S, Lund O, et al. NetMHCIIpan-2.0- improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immun Res 2010;6:9.
92. Blythe MJ, Flower DR. Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci 2005;14:246-8.
93. De Groot AS. Immunomics: discovering new targets for vaccines and therapeutics. Drug DiscovToday 2006;11: 203-09.
94. Reimer U. Prediction of linear B-cell epitopes. Methods Mol Biol (Clifton,NJ) 2009;524:335-44.
95. Ponomarenko JV, Bourne PE. Antibody-protein interactions: benchmark datasets and prediction tools evaluation. BMCStruct Biol 2007;7:64.
96. Chen J, Liu H, Yang J, et al. Prediction of linear B-cell epitopes using amino acid pair antigenicity scale. Amino Acids 2007;33:423-8.
97. El-Manzalawy Y, Dobbs D, Honavar V. Predicting linear B-cell epitopes using string kernels. JMolRecognit 2008;21: 243-55.
98. El-Manzalawy Y, Dobbs D, Honavar V. Predicting flexible length linear B-cell epitopes. ComputSyst BioinformaticsConf 2008;7:121-32.
99. Kolaskar AS, Tongaonkar PC. A semi empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990;276:172-4.
100. Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat AreasMol Biol 1978;47:45-8.
101. Emini EA, Hughes JV, Perlow DS, et al. Induction of hepatitis-A virus-neutralizing antibody by a virus-specific synthetic peptide. JVirol 1985;55:836-9.
102. Karplus PA, Schulz GE. Prediction of chain flexibility in proteins-a tool for the selection of peptide antigens. Naturwissenschaften 1985;72:212-3.
103. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid-chromatography peptide retention data: correlation of predicted surface residues with antigenicity and x-ray-derived accessible sites. Biochemistry 1986;25:5425-32.
104. Andersen PH, Nielsen M, Lund O. Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 2006;15:2558-67.
105. Nishikawa K, Ooi T. Prediction of the surface-interior diagram of globular-proteins by an empirical-method. Int J Pept Protein Res 1980;16:19-32.
106. Conesa A, Götz S, Garciá-Gómez JM, et al. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics 2005;21: 3674-6.
107. Vita R, Zarebski L, Greenbaum JA, et al. The immune epitope database 2.0. Nucleic Acids Res 2010;38:D854-62.
108. Sivashankari S, Shanmughavel P. Comparative genomics- a perspective. Bioinformation 2007;1:376-8.
109. Kimura M, Ohta T. Some principles governing molecular evolution. ProcNatl Acad SciUSA 1974;71:2848-52.
110. Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010;33: 530-41.
111. Margulies EH, Birney E. Approaches to comparative sequence analysis: towards a functional view of vertebrate genomes. Nat RevGenet 2008;9:303-13.
112. Zhu X, Goldberg AB. Introduction to semi-supervised learning. Synth Lect Artif Intell Machine Learn 2009;3:1-130.
113. Dziadek B, Gatkowska J, Grzybowski M, et al. Toxoplasma gondii: the vaccine potential of three trivalent antigencocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice. Exp Parasitol 2012;131:133-138.
114. Li WS, Chen QX, Ye JX, et al. Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses. Parasitol Res 2011;109:637-44.
115. Hiszczynska-Sawicka E, Li H, Xu JB, et al. Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. Exp Parasitol 2010;124:365-72.
116. Liddell S, Parker C, Vinyard B, et al. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum. J Parasitol 2003;89:496-500.
117. Hiszczynska-Sawicka E, Li H, Xu JB, et al. Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154. Vet Parasitol 2011;183: 72-8.
118. Ismael AB, Sekkai D, Collin C, et al. The MIC3 gene of Toxoplasmagondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 2003;71:6222-8.
119. Cannas A, Naguleswaran A, Muller N, et al. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology 2003;126:303-12.
120. Cho JH, Chung WS, Song KJ, et al. Protective efficacy of vaccination with Neospora caninum multiple recombinant antigens against experimental Neospora caninum infection. KoreanJ Parasitol 2005;43:19-25.
121. Liu KY, Zhang DB, Wei QK, et al. Biological role of surface Toxoplasma gondii antigen in development of vaccine. WorldJ Gastroenterol 2006;12:2363-8.
122. Nishikawa Y, Inoue N, Xuan XN, et al. Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection. Vaccine 2001;19:1381-90.
123. Rocchi MS, Bartley PM, Inglis NF, et al. Selection of Neospora caninum antigens stimulating bovine CD4(+ve) T cell responses through immuno-potency screening and proteomic approaches. Vet Res 2011;42:91.
124. Baszler TV, Shkap V, Mwangi W, et al. Bovine immune response to inoculation with Neospora caninum surface antigen SRS2 lipopeptides mimics immune response to infection with live parasites. ClinVaccine Immunol 2008;15: 659-67.
125. Haldorson GJ, Mathison BA, Wenberg K, et al. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice. Int J Parasitol 2005; 35:1407-15.
126. Nishikawa Y, Kousaka Y, Fukumoto S, et al. Delivery of Neospora caninum surface protein, NcSRS2 (Nc-p43), to mouse using recombinant vaccinia virus. Parasitol Res 2000;86:934-9.
127. Staska LM, Davies CJ, Brown WC, et al. Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4(+) cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected Holstein cattle. Infect Immun 2005;73:1321-9.
128. Ellis JT, Ryce C, Atkinson R, et al. Isolation, characterization and expression of a GRA2 homologue from Neospora caninum. Parasitology 2000;120:383-90.
129. Ramamoorthy S, Sanakkayala N, Vemulapalli R, et al. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens. IntJ Parasitol 2007;37: 1521-9.
130. Debache K, Alaeddine F, Guionaud C, et al. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. IntJParasitol 2009;39:1373-84.
131. Tuo WB, Fetterer R, Jenkins M, et al. Identification and characterization of Neospora caninum cyclophilin that elicits gamma interferon production. Infect Immun 2005; 73:5093-100.